Altered fovea in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders

被引:45
|
作者
Motamedi, Seyedamirhosein [1 ,2 ]
Oertel, Frederike C. [1 ,2 ,3 ]
Yadav, Sunil K. [2 ,4 ]
Kadas, Ella M. [2 ,4 ]
Weise, Margit [5 ]
Havla, Joachim [6 ]
Ringelstein, Marius [5 ,7 ]
Aktas, Orhan [5 ]
Albrecht, Philipp [5 ]
Ruprecht, Klemens [8 ]
Bellmann-Strobl, Judith [1 ,2 ]
Zimmermann, Hanna G. [1 ,2 ]
Paul, Friedemann [1 ,2 ,8 ]
Brandt, Alexander U. [1 ,2 ,9 ]
机构
[1] Max Delbruck Ctr Mol Med, Expt & Clin Res Ctr, Berlin, Germany
[2] Charite Univ Med Berlin, NeuroCure Clin Res Ctr, Berlin, Germany
[3] Univ Calif San Francisco, Div Neuroinflammat & Glial Biol, San Francisco, CA 94143 USA
[4] Nocturne GmbH, Berlin, Germany
[5] Heinrich Heine Univ, Fac Med, Dept Neurol, Dusseldorf, Germany
[6] Ludwig Maximilians Univ Munchen, LMU Hosp, Inst Clin Neuroimmunol, Munich, Germany
[7] LVR Klinikum Dusseldorf, Ctr Neurol & Neuropsychiat, Dept Neurol, Dusseldorf, Germany
[8] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany
[9] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA
来源
关键词
COHERENCE TOMOGRAPHY; RETINAL PATHOLOGY; AQUAPORIN-4; FEATURES; LAYER;
D O I
10.1212/NXI.0000000000000805
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective To investigate disease-specific foveal shape changes in patients with neuromyelitis optica spectrum disorders (NMOSDs) using foveal morphometry. Methods This cross-sectional study included macular spectral domain optical coherence tomography scans of 52 eyes from 28 patients with aquaporin-4 immunoglobulin G (AQP4-IgG)-seropositive NMOSD, 116 eyes from 60 patients with MS, and 123 eyes from 62 healthy controls (HCs), retrospectively, and an independent confirmatory cohort comprised 33/33 patients with NMOSD/MS. The fovea was characterized using 3D foveal morphometry. We included peripapillary retinal nerve fiber layer (pRNFL) thickness and combined macular ganglion cell and inner plexiform layer (GCIPL) volume to account for optic neuritis (ON)-related neuroaxonal damage. Results Group comparison showed significant differences compared with HC in the majority of foveal shape parameters in NMOSD, but not MS. Pit flat disk area, average pit flat disk diameter, inner rim volume, and major slope disk length, as selected parameters, showed differences between NMOSD and MS (p value = 0.017, 0.002, 0.005, and 0.033, respectively). This effect was independent of ON. Area under the curve was between 0.7 and 0.8 (receiver operating characteristic curve) for discriminating between NMOSD and MS. Pit flat disk area and average pit flat disk diameter changes independent of ON were confirmed in an independent cohort. Conclusions Foveal morphometry reveals a wider and flatter fovea in NMOSD in comparison to MS and HC. Comparison to MS and accounting for ON suggest this effect to be at least in part independent of ON. This supports a primary retinopathy in AQP4-IgG-seropositive NMOSD.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Paraneoplastic seropositive AQP4-IgG neuromyelitis optica spectrum disorder associated with sigmoid adenocarcinoma
    Hassan, Sarah Hasnor Abu
    Sonu, Sumit Kumar
    NEUROLOGY ASIA, 2023, 28 (03) : 769 - 774
  • [22] Brain MRI abnormalities in MOG-IgG and AQP4-IgG seropositive neuromyelitis optica spectrum disorder
    Schmidt, F.
    Borisow, N.
    Ruprecht, K.
    Bellmann-Strobl, J.
    Brandt, A.
    Paul, F.
    Scheel, M.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 636 - 636
  • [23] Neuromyelitis optica spectrum disorders: comparison of clinical and MRI characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands
    van Pelt, E. D.
    Wong, Y. Y.
    Ketelslegers, I. A.
    Hamann, D.
    Hintzen, R. Q.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 372 - 372
  • [24] Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study
    Schmidt, Felix A.
    Chien, Claudia
    Kuchling, Joseph
    Bellmann-Strobl, Judith
    Ruprecht, Klemens
    Siebert, Nadja
    Asseyer, Susanna
    Jarius, Sven
    Brandt, Alexander U.
    Scheel, Michael
    Paul, Friedemann
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [25] AQP4-IgG antibodies as biomarkers for early diagnosis of neuromyelitis optica spectrum disorders
    Mader, Simone
    Deisenhammer, Florian
    Reindl, Markus
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2010, 34 (06): : 337 - 342
  • [26] Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders
    Palace, Jacqueline
    Lin, Dan-Yu
    Zeng, Donglin
    Majed, Masoud
    Elsone, Liene
    Hamid, Shand
    Messina, Silvia
    Misu, Tatsuro
    Sagen, Jessica
    Whittam, Daniel
    Takai, Yoshiki
    Leite, Maria Isabel
    Weinshenker, Brian
    Cabre, Philippe
    Jacob, Anu
    Nakashima, Ichiro
    Fujihara, Kazuo
    Pittock, Sean J.
    BRAIN, 2019, 142 : 1310 - 1323
  • [27] Increased expression of the membrane-bound CD40 ligand on peripheral CD4+ T cells in the acute phase of AQP4-IgG-seropositive neuromyelitis optica spectrum disorders
    Liu, Ju
    Zhang, Qin
    Shi, Ziyan
    Yang, Mu
    Lian, Zhiyun
    Chen, Hongxi
    Feng, Huiru
    Du, Qin
    Zhang, Ying
    Miao, Xiaohui
    Li, Huifang
    Zhou, Hongyu
    JOURNAL OF NEUROIMMUNOLOGY, 2018, 325 : 64 - 68
  • [28] Cytoprotective IgG antibodies in sera from a subset of patients with AQP4-IgG seropositive neuromyelitis optica spectrum disorder
    Tradtrantip, Lukmanee
    Yeaman, Michael R.
    Verkman, A. S.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [29] Cytoprotective IgG antibodies in sera from a subset of patients with AQP4-IgG seropositive neuromyelitis optica spectrum disorder
    Lukmanee Tradtrantip
    Michael R. Yeaman
    A. S. Verkman
    Scientific Reports, 11
  • [30] Real-word efficacy data of azathioprine in AQP4-IgG seropositive neuromyelitis optica spectrum disorder
    Papp, V.
    Saleem, R.
    Magyari, M.
    Koch-Henriksen, N.
    Iljicsov, A.
    Rajda, C.
    Nielsen, H. H.
    Lovas, G.
    Rozsa, C.
    Stenager, E.
    Frederiksen, J. L.
    Komoly, S.
    Petersen, T.
    Sellebjerg, F.
    Illes, Z.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 559 - 560